Clinical Trial Update: A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab [Phase 3]

View source ↗

Summary

Phase 3 study in Korean postmenopausal women with osteoporosis evaluating denosumab completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED | Results posted: 2013-10-29